DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 167 filers reported holding DIPLOMAT PHARMACY INC in Q3 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,308,000 | -60.2% | 1,077,089 | -51.2% | 0.00% | -50.0% |
| Q3 2019 | $10,811,000 | +25.2% | 2,206,274 | +52.6% | 0.00% | 0.0% |
| Q2 2019 | $8,632,000 | +403.3% | 1,445,834 | +390.0% | 0.00% | – |
| Q1 2019 | $1,715,000 | +72.0% | 295,094 | +298.3% | 0.00% | – |
| Q4 2018 | $997,000 | -75.8% | 74,085 | -65.2% | 0.00% | -100.0% |
| Q3 2018 | $4,128,000 | -68.8% | 212,669 | -58.9% | 0.00% | -66.7% |
| Q2 2018 | $13,220,000 | -31.3% | 517,236 | -45.8% | 0.00% | -25.0% |
| Q1 2018 | $19,237,000 | -6.1% | 954,656 | -6.5% | 0.00% | 0.0% |
| Q4 2017 | $20,487,000 | +77.1% | 1,020,769 | +80.9% | 0.00% | +33.3% |
| Q3 2017 | $11,571,000 | +176.6% | 564,120 | +99.6% | 0.00% | +200.0% |
| Q2 2017 | $4,183,000 | +3506.0% | 282,622 | +3806.3% | 0.00% | – |
| Q1 2017 | $116,000 | +123.1% | 7,235 | +73.1% | 0.00% | – |
| Q4 2016 | $52,000 | -61.2% | 4,179 | -12.9% | 0.00% | – |
| Q3 2016 | $134,000 | -98.6% | 4,796 | -98.3% | 0.00% | -100.0% |
| Q2 2016 | $9,648,000 | +25.0% | 275,647 | -2.1% | 0.00% | 0.0% |
| Q1 2016 | $7,718,000 | -2.8% | 281,635 | +21.4% | 0.00% | 0.0% |
| Q4 2015 | $7,939,000 | +81.6% | 232,005 | +52.5% | 0.00% | +100.0% |
| Q3 2015 | $4,372,000 | +718.7% | 152,167 | +885.4% | 0.00% | – |
| Q1 2015 | $534,000 | +21.6% | 15,442 | -3.8% | 0.00% | – |
| Q4 2014 | $439,000 | – | 16,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|